nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—CHRND—cardiovascular system—attention deficit hyperactivity disorder	0.0175	0.0963	CbGeAlD
Tubocurarine—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0144	0.0789	CbGeAlD
Tubocurarine—HTR3A—forebrain—attention deficit hyperactivity disorder	0.0103	0.0564	CbGeAlD
Tubocurarine—CHRNB1—midbrain—attention deficit hyperactivity disorder	0.00883	0.0485	CbGeAlD
Tubocurarine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00857	0.047	CbGeAlD
Tubocurarine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00841	0.0462	CbGeAlD
Tubocurarine—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.0078	0.0428	CbGeAlD
Tubocurarine—ACHE—midbrain—attention deficit hyperactivity disorder	0.00765	0.042	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.00751	0.0412	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.00734	0.0403	CbGeAlD
Tubocurarine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00724	0.0398	CbGeAlD
Tubocurarine—CHRNA1—brain—attention deficit hyperactivity disorder	0.00718	0.0394	CbGeAlD
Tubocurarine—CHRNB1—cerebellum—attention deficit hyperactivity disorder	0.00683	0.0375	CbGeAlD
Tubocurarine—CHRNA2—brain—attention deficit hyperactivity disorder	0.00596	0.0327	CbGeAlD
Tubocurarine—ACHE—cerebellum—attention deficit hyperactivity disorder	0.00592	0.0325	CbGeAlD
Tubocurarine—HTR3A—nervous system—attention deficit hyperactivity disorder	0.00557	0.0306	CbGeAlD
Tubocurarine—CHRNB1—brain—attention deficit hyperactivity disorder	0.00555	0.0305	CbGeAlD
Tubocurarine—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.00537	0.0295	CbGeAlD
Tubocurarine—ACHE—brain—attention deficit hyperactivity disorder	0.00481	0.0264	CbGeAlD
Tubocurarine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00465	0.0255	CbGeAlD
Tubocurarine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00457	0.0251	CbGeAlD
Tubocurarine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00448	0.0246	CbGeAlD
Tubocurarine—CHRND—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00443	0.00541	CbGpPWpGaD
Tubocurarine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.0044	0.0242	CbGeAlD
Tubocurarine—HTR3A—brain—attention deficit hyperactivity disorder	0.00426	0.0234	CbGeAlD
Tubocurarine—ACHE—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00417	0.00509	CbGpPWpGaD
Tubocurarine—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00383	0.00468	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00376	0.0046	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00365	0.00446	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00358	0.00437	CbGpPWpGaD
Tubocurarine—SLC22A1—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00357	0.00436	CbGpPWpGaD
Tubocurarine—CHRM2—brain—attention deficit hyperactivity disorder	0.00355	0.0195	CbGeAlD
Tubocurarine—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00351	0.00429	CbGpPWpGaD
Tubocurarine—SLC22A1—brain—attention deficit hyperactivity disorder	0.00349	0.0192	CbGeAlD
Tubocurarine—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00339	0.00415	CbGpPWpGaD
Tubocurarine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00338	0.00414	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00332	0.00406	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00328	0.00402	CbGpPWpGaD
Tubocurarine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00328	0.00401	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00323	0.00395	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00319	0.0039	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00307	0.00375	CbGpPWpGaD
Tubocurarine—SLC22A1—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00306	0.00374	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00297	0.00363	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00296	0.00362	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00289	0.00353	CbGpPWpGaD
Tubocurarine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00288	0.00352	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00285	0.00349	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00285	0.00349	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00276	0.00338	CbGpPWpGaD
Tubocurarine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00273	0.00334	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00271	0.00332	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00268	0.00328	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00265	0.00324	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00265	0.00324	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00254	0.00311	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00251	0.00307	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0025	0.00305	CbGpPWpGaD
Tubocurarine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00247	0.00302	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00239	0.00292	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00236	0.00289	CbGpPWpGaD
Tubocurarine—SLC22A1—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0023	0.00281	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0023	0.00281	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0023	0.00281	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00227	0.00277	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00221	0.0027	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00219	0.00268	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00216	0.00264	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00214	0.00262	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00211	0.00258	CbGpPWpGaD
Tubocurarine—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00208	0.00254	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00205	0.00251	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00201	0.00246	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.002	0.00244	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00195	0.00239	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00195	0.00238	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00193	0.00236	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00193	0.00236	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00191	0.00233	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00191	0.00233	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00183	0.00224	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00182	0.00223	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00181	0.00221	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00179	0.00219	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00179	0.00219	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00178	0.00217	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00176	0.00215	CbGpPWpGaD
Tubocurarine—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00175	0.00214	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0017	0.00208	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00166	0.00203	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00164	0.00201	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00163	0.00199	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00161	0.00197	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00157	0.00192	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00154	0.00188	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00152	0.00186	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00151	0.00185	CbGpPWpGaD
Tubocurarine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0015	0.00183	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00148	0.00181	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00146	0.00179	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00146	0.00178	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00145	0.00177	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00144	0.00176	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00142	0.00173	CbGpPWpGaD
Tubocurarine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00139	0.00171	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.00168	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00137	0.00168	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00136	0.00167	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.00159	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00128	0.00156	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00127	0.00155	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00122	0.0015	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00119	0.00145	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00117	0.00143	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
Tubocurarine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00115	0.00141	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00113	0.00138	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00111	0.00136	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.0011	0.00135	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0011	0.00134	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00105	0.00129	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.00129	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00102	0.00125	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00124	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00101	0.00124	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000996	0.00122	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000993	0.00121	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000979	0.0012	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000979	0.0012	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000973	0.00119	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000947	0.00116	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000944	0.00115	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000941	0.00115	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000926	0.00113	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000924	0.00113	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000905	0.00111	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000902	0.0011	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000895	0.00109	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00089	0.00109	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000889	0.00109	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000883	0.00108	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000877	0.00107	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000868	0.00106	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000863	0.00105	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000841	0.00103	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000839	0.00103	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000807	0.000986	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000805	0.000985	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000799	0.000977	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000782	0.000956	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000776	0.000948	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000774	0.000946	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000759	0.000928	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000758	0.000927	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000737	0.000901	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000723	0.000884	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000721	0.000882	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000713	0.000872	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000711	0.000869	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000708	0.000866	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000704	0.000861	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00069	0.000844	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000686	0.000839	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000683	0.000835	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000681	0.000833	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00068	0.000831	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000672	0.000822	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000671	0.000821	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000665	0.000813	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000663	0.000811	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00066	0.000807	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000655	0.0008	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000652	0.000797	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000643	0.000786	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000634	0.000775	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000634	0.000775	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000623	0.000762	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000618	0.000755	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000615	0.000752	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000603	0.000737	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.0006	0.000734	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000599	0.000732	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000592	0.000724	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000573	0.000701	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000561	0.000686	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000546	0.000668	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000543	0.000664	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000543	0.000663	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000534	0.000653	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000527	0.000645	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000525	0.000642	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000509	0.000623	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000506	0.000618	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000491	0.0006	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000459	0.000562	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000437	0.000535	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000428	0.000524	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000427	0.000522	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000414	0.000506	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000413	0.000505	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000407	0.000497	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000402	0.000491	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000401	0.000491	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000398	0.000487	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000397	0.000486	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000389	0.000476	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000374	0.000457	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00035	0.000428	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000346	0.000422	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000344	0.000421	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000329	0.000402	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000322	0.000394	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000318	0.000389	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000307	0.000375	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000297	0.000363	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000285	0.000349	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000285	0.000349	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00028	0.000343	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000273	0.000334	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00027	0.00033	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000262	0.00032	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000261	0.000319	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00026	0.000317	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000241	0.000295	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000236	0.000288	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000235	0.000287	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000234	0.000286	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00023	0.000281	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00023	0.000281	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000228	0.000279	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000227	0.000278	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000227	0.000278	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000227	0.000277	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000225	0.000276	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000223	0.000273	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000219	0.000268	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000265	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000212	0.000259	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000212	0.000259	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000212	0.000259	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000211	0.000258	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000209	0.000255	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000208	0.000255	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000208	0.000254	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000206	0.000252	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000194	0.000237	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000192	0.000235	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000182	0.000222	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.000211	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000173	0.000211	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000171	0.00021	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000169	0.000207	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000166	0.000203	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000161	0.000197	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000159	0.000195	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000148	0.000181	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000139	0.00017	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000138	0.000168	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000137	0.000167	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000134	0.000164	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000129	0.000158	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000128	0.000157	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000127	0.000156	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000125	0.000153	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000123	0.000151	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000122	0.000149	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000113	0.000139	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.94e-05	9.71e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	7.41e-05	9.06e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.9e-05	7.22e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.5e-05	6.72e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.21e-05	5.14e-05	CbGpPWpGaD
